Cargando…
Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent
PURPOSE: For 30 years nature has provided a plethora of natural products with potential meaningful anti-cancer activity. Fusarochromanone (FC101a) is a small molecule fungal metabolite exhibiting potent in-vitro growth inhibitory effects and is capable of inducing apoptosis, suppressing angiogenesis...
Autores principales: | El-Saadi, Madison Wynne, Williams-Hart, Tara, Salvatore, Brian A, Mahdavian, Elahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464579/ https://www.ncbi.nlm.nih.gov/pubmed/26820891 http://dx.doi.org/10.1186/s40203-015-0010-5 |
Ejemplares similares
-
TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
por: Carroll, Natalie, et al.
Publicado: (2022) -
Biological activities of fusarochromanone: a potent anti-cancer agent
por: Mahdavian, Elahe, et al.
Publicado: (2014) -
Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanone
por: MAHDAVIAN, ELAHE, et al.
Publicado: (2014) -
Fusarochromanone Induces G(1) Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells
por: Gu, Ying, et al.
Publicado: (2014) -
Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5
por: Gu, Ying, et al.
Publicado: (2015)